GlassScriptPhysician profile
Naveen R Bethi
NPI 1952330011
$14,292.86
in general payments reported to CMS, 2019-2025
50 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,085 · 2020: $2,210 · 2021: $2,264 · 2022: $2,104 · 2023: $2,001 · 2024: $1,788 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,629.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,002.45 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,816.58 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $1,468.88 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $1,183.63 | 2019-2025 | Rybelsus, Ozempic, Tresiba |
| Lilly USA, LLC | $965.62 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $758.29 | 2019-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $667.16 | 2019-2024 | Synjardy, Jardiance, Tradjenta |
| Pfizer INC. | $527.74 | 2019-2025 | |
| Astellas Pharma US INC | $494.03 | 2019-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $487.08 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $429.06 | 2019-2025 | |
| Amgen INC. | $356.33 | 2019-2025 | Otezla, Repatha, Evenity |
| Merck Sharp & Dohme LLC | $329.44 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Sanofi-Aventis U.S. LLC | $307.22 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $298.02 | 2019-2023 | Xarelto |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $182.81 | 2022-2025 | Intellis Adaptivestim, Minimed 780g, Minimed 770g |
| Ironwood Pharmaceuticals, INC | $175.36 | 2019-2024 | |
| Daiichi Sankyo INC. | $153.92 | 2019-2025 | Injectafer |
| Allergan, INC. | $146.02 | 2020 | |
| Abbott Laboratories | $143.31 | 2019-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Antares Pharma, INC. | $122.87 | 2021-2025 | Xyosted |
| Exact Sciences Corporation | $101.04 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sunovion Pharmaceuticals INC. | $100.17 | 2019 | |
| Esperion Therapeutics, INC. | $94.01 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $87.11 | 2025 | Caplyta |
| Dexcom, INC. | $86.36 | 2021-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $79.70 | 2022 | |
| Vanda Pharmaceuticals INC. | $62.54 | 2024-2025 | Hetlioz, Fanapt |
| Optinose US, INC. | $53.43 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $52.87 | 2019-2023 | Eliquis |
| Insmed, INC. | $50.13 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $48.84 | 2022-2023 | Gvoke Hypopen |
| Boston Scientific Corporation | $44.35 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Philips North America LLC | $43.95 | 2020 | |
| Inspire Medical Systems, INC. | $42.11 | 2025 | Inspire |
| Organon LLC | $38.79 | 2025 | Nexplanon |
| Shield Therapeutics INC | $36.30 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $32.55 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $31.82 | 2020-2021 | |
| Corcept Therapeutics | $20.62 | 2023 | Korlym |
| Neurocrine Biosciences, INC. | $19.65 | 2025 | |
| Lucid Diagnostics INC. | $19.41 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $19.26 | 2022 | |
| Phathom Pharmaceuticals, INC. | $19.15 | 2025 | Voquezna |
| Fidia Pharma USA INC. | $18.59 | 2019 | |
| Sanofi Pasteur INC. | $18.23 | 2019 | |
| Axsome Therapeutics, INC. | $15.65 | 2024 | Auvelity |
| Eisai INC. | $15.19 | 2019 | |
| Genentech USA, INC. | $13.80 | 2019 | |
| Horizon Therapeutics Plc | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Bethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.